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A B S T R A C T
In addition to the development of beta amyloid plaques and neurofibrillary tangles, Alzheimer's disease (AD)
involves the loss of connecting structures including degeneration of myelinated axons and synaptic connections.
However, the extent to which white matter tracts change longitudinally, particularly in the asymptomatic,
preclinical stage of AD, remains poorly characterized. In this study we used a novel graph wavelet algorithm to
determine the extent to which microstructural brain changes evolve in concert with the development of AD
neuropathology as observed using CSF biomarkers. A total of 118 participants with at least two diffusion tensor
imaging (DTI) scans and one lumbar puncture for CSF were selected from two observational and longitudinally
followed cohorts. CSF was assayed for pathology specific to AD (Aβ42 and phosphorylated-tau), neurodegen-
eration (total-tau), axonal degeneration (neurofilament light chain protein; NFL), and synaptic degeneration
(neurogranin). Tractography was performed on DTI scans to obtain structural connectivity networks with 160
nodes where the nodes correspond to specific brain regions of interest (ROIs) and their connections were defined
by DTI metrics (i.e., fractional anisotropy (FA) and mean diffusivity (MD)). For the analysis, we adopted a multi-
resolution graph wavelet technique called Wavelet Connectivity Signature (WaCS) which derives higher order
representations from DTI metrics at each brain connection. Our statistical analysis showed interactions between
the CSF measures and the MRI time interval, such that elevated CSF biomarkers and longer time were associated
with greater longitudinal changes in white matter microstructure (decreasing FA and increasing MD).
Specifically, we detected a total of 17 fiber tracts whose WaCS representations showed an association between
longitudinal decline in white matter microstructure and both CSF p-tau and neurogranin. While development of
neurofibrillary tangles and synaptic degeneration are cortical phenomena, the results show that they are also
associated with degeneration of underlying white matter tracts, a process which may eventually play a role in
the development of cognitive decline and dementia.
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1. Introduction
Loss of white matter connectivity is an increasingly recognized
feature of Alzheimer's disease (AD) and other dementias (Jung et al.,
2014; Mahoney et al., 2015; Mascalchi et al., 2017; Meijboom et al.,
2017; Racine et al., 2017b). Post mortem, biochemical, and brain
imaging studies show extensive white matter degeneration in AD
(Balthazar et al., 2009; Baxter et al., 2006; Chaim et al., 2007; Im et al.,
2008; Racine et al., 2017b; Salat et al., 2009; Teipel et al., 1998;
Vermersch et al., 1994). However, the temporal emergence of white
matter disconnection abnormalities and their interactions with cortical
pathology are not well defined. Studies using diffusion tensor imaging
(DTI) acquired in concert with cerebrospinal fluid (CSF) measures of AD
pathology show that greater concentration of AD neuropathology is
associated with altered microstructure among individuals with mild
cognitive impairment (MCI) and AD (Li et al., 2014; Stenset et al.,
2011), as well as among cognitively asymptomatic middle-aged and
older adults (Bendlin et al., 2012; Gold et al., 2014; Molinuevo et al.,
2014). The observed white matter changes may be an independent but
co-occurring feature of AD, or it may be that amyloidogenic and neu-
rodegenerative processes drive white matter changes very early in the
disease course.
Longitudinal in vivo measurements of white matter microstructure
are expected to shed light on how white matter alterations evolve in
disease. Furthermore, given that changes in cognitively asymptomatic
populations may be subtle, highly sensitive approaches are essential. In
our recent work, we showed that using a multi-resolution analysis can
significantly improve sensitivity to subtle alterations in white matter
connectivity, in addition to providing a method for maintaining sensi-
tivity in the face of multiple comparisons which are common in neu-
roimaging studies (Kim et al., 2013; 2015a). Considering a brain con-
nectivity as a graph that consists of nodes and edges, we previously
proposed a Wavelet Connectivity Signature (WaCS) that enables a
multi-resolution view (i.e., coarse-to-fine details) of measures for con-
nectivity strength between regions of interest (ROIs). In the traditional
Euclidean setting (e.g.1-D or 2-D), multi-resolution view of a signal is
obtained by performing band-pass filter operations in the frequency
space. In our case where the domain is a graph, we leverage spectral
graph theory to define its dual space (i.e., an analogue of the frequency
space) and perform band-pass filtering in different bandwidths to ob-
tain coarse-to-fine details of a signal on the graph. This operation yields
the multi-resolution characteristics to define WaCS, which is essentially
a higher-order representation that takes into account the connectivity
strength of the specific fiber bundle concurrently with the connectivity
strength of other fiber bundles in a graph theoretic sense (Kim et al.,
2015a). Utilizing WaCS has shown improved sensitivity for detecting
group differences and brain alterations present in neuroimaging data
over the use of raw measurements only (Hwang et al., 2018a; Kim et al.,
2013; 2015a; 2012; 2015b; 2014).
To investigate whether development of AD pathology is associated
with progressively impaired connectivity of white matter, we examined
the relationship between changes in WaCS based representations over
an average of 2.7 years and CSF biomarkers of amyloid (Aβ42), neu-
rofibrillary tangles (p-tau), axonal degeneration (neurofilament light
chain protein; NFL), and synaptic dysfunction (neurogranin).
Participants were late middle aged and cognitively asymptomatic, al-
though several participants harbored increased risk for AD due to
parental family history and APOE ε4 genotype. We hypothesized that
biomarker levels indicative of greater AD pathology would be asso-
ciated with decreased white matter connectivity strength captured in
the multi-resolution WaCS representations, measured over time. This
would suggest that elevated AD pathology is at least one driver of white
matter degeneration, serving as a possible biological substrate under-
lying progressive cognitive impairment. Our paradigm also allowed us
to test the utility of WaCS based signatures for detecting subtle changes
in the longitudinal setting.
2. Materials and methods
2.1. Participants
We combined data collected from cognitively asymptomatic parti-
cipants enrolled in two longitudinal cohort studies: 1) the Wisconsin
Registry for Alzheimer's Prevention (WRAP) study and 2) the Wisconsin
Alzheimer's Disease Research Center (ADRC). The WRAP is a long-
itudinal observational study of middle-aged adults who were cogni-
tively normal at study entry, and approximately 70% of the cohort has a
parental history of AD. The Wisconsin ADRC clinical core comprises
participants at various AD stages ranging from cognitively asympto-
matic to having dementia due to AD; to investigate early white matter
changes, we limited our analysis to participants who were non-de-
mented. In sum, the present investigation included 118 participants
who were non-demented at cohort entry, completed at least two DTI
scans, and underwent CSF collection by lumbar puncture (Racine et al.,
2016). Among the 118 participants, n= 11 were Wisconsin ADRC
subjects (mean age 55.57 years, σ = 6.62) and n= 107 were WRAP
subjects (mean age 60.41 years, σ = 6.31). The mean age for the total
sample (40 males and 78 females) was 59.8 (σ = 6.16) and the mean
time period between the two DTI visits was 2.73 years (σ = 1.29). The
University of Wisconsin Institutional Review Board approved all study
procedures, each participant provided signed informed consent before
participation, and all research was completed in accordance with the
Helsinki Declaration. Also, the data that support the findings of this
study are available from the corresponding author upon reasonable
request without any information that may indicate specific participant
in the study. The full demographics are reported in Table 1.
2.2. MRI acquisition
Participants were imaged on two identical General Electric 3.0 Tesla
Discovery MR750 (Waukesha, WI) MRI systems fitted with an 8-
channel head coil and using parallel imaging (ASSET). All participants
in the W-ADRC dataset were imaged on one scanner, while all WRAP
participants were imaged on a second, identical scanner. For both co-
horts, Diffusion Tensor Imaging (DTI) was acquired using a diffusion-
weighted, spin-echo, single-shot, echo planar imaging (EPI) pulse se-
quence in 40 encoding directions at b=1300 s/mm2, with eight non-
diffusion weighted (b= 0) reference images. The cerebrum was cov-
ered using contiguous 2.5mm thick axial slices, FOV=24 cm,
TR=8000ms, TE=67.8ms, matrix= 96×96, resulting in isotropic
2.5 mm3 voxels. High order shimming was performed prior to the DTI
acquisition to optimize the homogeneity of the magnetic field across the
brain and to minimize EPI distortions. We employed a robust processing
pipeline, based on methods in (Adluru et al., 2014). The eddy current
correction, field map correction and brain mask segmentation were
performed using tools from FSL, and the tensors were estimated using
non-linear least squares method.
2.3. Deriving brain connectivity networks
Brain connectivity networks were derived using a 3-step process.
Table 1
Demographics of the Wisconsin Registry for Alzheimer's Prevention (WRAP)
and the Wisconsin Alzheimer's Disease Research Center (ADRC).
Demographics WRAP Wisconsin ADRC Total
Number of subjects 107 11 118
Sex (M/F) 39/68 1/10 40/78
Age (mean/σ) 60.42/6.31 55.57/6.62 59.80/6.16
Ptau in pg/ml (mean/σ) 43.07/13.23 40.72/10.85 42.85/13
Neurogranin in pg/ml
(mean/σ)
386.24/
165.56
404.61/151.71 387.96/163.8
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2.3.1. Coordinate system
Image registration was achieved following recommended proce-
dures for deriving an unbiased coordinate system for 4D data
(Keihaninejad et al., 2013). This approach reduces interpolation
asymmetry that can arise if one were to select only one time point in a
longitudinal dataset when generating the population/study level co-
ordinate system as described in recent works (Keihaninejad et al., 2013;
Yushkevich et al., 2010). We first estimated a subject-specific average
that is temporally unbiased. The subject specific averages were then
used to generate an unbiased population level average template space.
Image registration was achieved using the Diffusion Tensor Imaging
Toolkit (DTI-TK, http://dti-tk.sourceforge.net/pmwiki/pmwiki.php),
an empirically validated software that supports affine and diffeo-
morphic transformations while allowing tensor interpolation and re-
orientation.
2.3.2. Nodes
The second step involved definition of node regions in gray matter.
This was achieved using the gray matter atlas defined on a publicly
available Illinois Institute of Technology-Diffusion Tensor Image (IIT-
DTI) template (Varentsova et al., 2014) which provides 160 distinct
brain regions (discarded regions labelled as ‘unknown’ and ‘cere-
bellum’). These regions (i.e., nodes) varies in their size and defined
based on anatomical prior, and they share partial volume with the
white matter around their boundaries due to limited MRI resolution.
The white matter fiber tracts end in these regions due to stopping cri-
teria used in the tracking algorithm.
The fractional anisotropy (FA) map of the IIT-DTI template provided
a co-registered FA image with its gray matter atlas. Since our popula-
tion atlas provide FA images and not T1-weighted images, we per-
formed FA to FA registration by employing advanced normalization
tools (ANTS, http://picsl.upenn.edu/software/ants). Here, the FA map
was the fixed image and the IIT-DTI-FA image was the moving image.
This FA to FA registration produced accurate registration between the
IIT atlas and our population average FA image. The resulting trans-
formation was then applied to the integer valued gray-matter atlas map
with nearest neighbor interpolation to provide the 160 regions in the
population coordinate system.
2.3.3. Edges/links in the connectivity graph
In the third step, we performed tractography to derive brain edges
representing the structural networks/graph. The edges are composed of
fiber bundles connecting pairs of gray matter regions, and they have
rich information such as their tract curvatures and torsions (i.e., geo-
metric shape information) as well as DTI measures defined along these
tracts (i.e., functional values). Data were fit with a diffusion tensor
model. The principal eigenvector of the diffusion tensor in a voxel
provides a proxy to the predominant orientation of the white matter
fibers in that voxel. A key factor in tractography algorithms is error
accumulation. The two key techniques we employed to avoid the error
issue were bootstrapping and tensor deflection (TEND) interpolation.
Using this information, we repeated probabilistic tractography 20 times
with implementations available in (Cook et al., 2006). Since the goal of
this study is to identify fiber pathways connecting pairs of specific gray
matter regions, we started the streamlines from each node region. For
each pair of nodes, we merged the region-wise fibers and then filtered
them to include only those that pass through both the regions. During
the tractography processing, we found this approach produced quali-
tatively better fiber connections (i.e., lower false positives) compared to
the streamlines that starts from the whole brain as a seed file and ap-
plying pairs of gray matter regions as end-point filters. The other cri-
teria for tractography (for reproducibility) were as follows: (i) Curva-
ture threshold of 45 degrees checked every 10mm for stopping, and (ii)
Euler integration step size of 0.1mm for streamline generation. The
stopping criteria did not involve any FA thresholding since the tracts
are filtered using the gray matter regions. For tracking purpose, the
gray matter regions were dilated twice but this was not for filtering. We
used Camino (Cook et al., 2006) package to implement our protocol.
Once the tracts connecting the pairwise gray matter ROIs were re-
constructed, mean diffusivity (MD) and average FA in these tracts then
served as the edge strength between the nodes.
2.4. Cerebrospinal fluid (CSF) biomarkers
CSF samples were collected after a minimum 4-hour fast and pro-
cessed in the same manner as in (Starks et al., 2015). CSF t-tau, p-
tau181 and Aβ42 were assayed using commercially available enzyme-
linked immunosorbent assays (ELISA) (INNOTEST, Fujirebio, Ghent
Belgium). Neurogranin concentration was measured using an in house
ELISA and NFL was measured using the NF-Light kit from UmanDiag-
nostics (Umeå, Sweden), as previously described in (Mattsson et al.,
2016). Lower levels of CSF Aβ42 indicate greater amyloid burden in the
brain (Racine et al., 2016). High levels of NFL, neurogranin and p-tau
respectively indicate axonal degeneration, synaptic degeneration and
neurofibrillary tangle burden. CSF assays were completed in two se-
parate batches. Due to minor batch-related differences in the compo-
nents of research-grade assays, the values of a CSF analyte in one batch
are not necessarily directly comparable to that same CSF analyte as-
sayed in a different batch (Zhou et al., 2018). We therefore corrected
for batch using a simple linear regression (SLR) model as described
previously in (Racine et al., 2016), with the exception of NFL which was
comparable between the two batches. Additionally, a square root
transform was applied to neurogranin to correct for heteroscedasticity.
These CSF measures together with the DTI metrics has been previously
assessed in a longitudinal analysis as in (Racine et al., 2017a).
2.5. Multi-resolution connectivity signature using wavelet transform on
graphs
The goal of this study was to identify brain connections that show
close associations between longitudinal changes in structural brain
connectivity and AD neuropathology as indexed by the CSF measures.
To increase the sensitivity of our analysis, we adopted WaCS metho-
dology introduced in (Kim et al., 2013; 2015a) which derives multi-
resolution (higher order) descriptors on edges of a graph. WaCS obtains
context information in multiple resolutions on graph edges based on the
connectivity information of a graph. Such a multi-resolution strategy is
the intuition behind feature descriptor matching schemes widely used
in computer vision, where an image is considered as a continuous signal
(Lowe, 2004; Morel and Yu, 2009; Shen and Ip, 1999). These traditional
approaches for multi-resolution are not directly applicable on a com-
plex domain such as brain connectivity graphs since they work only for
signals in Euclidean spaces. Fortunately, wavelet transforms for graphs
recently became available (Coifman and Maggioni, 2006; Hammond
et al., 2011) which enable one to derive multi-resolution from signals
defined in non-Euclidean spaces.
As described in (Kim et al., 2015a), in traditional wavelet ap-
proaches, a wavelet basis ψs, a(x) (i.e., a mother wavelet), an oscillating
function at a specific scale s (i.e., dilation) centred at a specific location
a, is first defined over the domain x in a Euclidean space. Given a signal
f(x), this pre-defined basis function ψs, a(x) at multiple scales is used for
the wavelet transform which derives the multi-resolution perspective of
the original signal. However, when it comes to a graph, it is difficult to
define such a basis function over the graph nodes n because the con-
cepts of scale and localization become ambiguous with arbitrary
structure of a graph. Spectral graph wavelet transform (SGWT) in
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(Hammond et al., 2011) overcame this difficulty by defining a wavelet
in a 1D dual space which is an analogue of the frequency space and
localizing it in the original space. To define the dual space, eigenvalues
and eigenvectors pairs of a graph Laplacian (λl,χl), l= 0, 1, ⋯, N is
used to define graph Fourier transform that acts on a signal f(n) as
= = = n nf (l) f, f( ) ( )nN ll 1
where the f (l) is the resultant graph Fourier coefficient. Then, the
wavelet basis is defined in the graph Fourier space as a kernel function g
(λl) as
= =m g s m n( ) ( ) ( ) ( )s n lN l l l, 01
where the g() is a band-pass filter that represents a traditional wavelet
basis in the frequency space. Here, the shape of the kernel function g()
determines the shape of the wavelet basis ψs, n in the original graph
space. With a mother wavelet ψs, n at hand, the spectral graph wavelet
transform of a function f(n) is defined as
= = =s n f g f l nW ( , ) , (s ) ( ) ( )f s n lN l l, 01
yielding a wavelet coefficient Wf(s,n) at scale s at centered n. The
wavelet coefficients are the key ingredient to derive a multi-resolution
view of a signal at different scales which encode coarse to fine details of
the original signal at different scales.
To obtain WaCS, we need to take one step further. First, a brain
network is considered as a graph G∈ {V,E,ω} where the gray matter
regions of interest (ROIs) become the nodes V and the edges E denote
their connections/relations where the strength of the connections is
described by the edge weights ω. Since the signal that we want to
analyze is on the edges and not on the nodes, the SGWT described
above cannot be applied directly. We therefore utilize a concept of a
dual graph, i.e., a line graph L(G) of G that simply exchanges the roles
of vertices and edges (Harary, 1969). Together with the SGWT, we
obtain multi-resolution view of the edge signal (i.e., ω) via wavelet
coefficients W(s,e) at each edge e at scale s as described in (Kim et al.,
2013; 2015a) as
= s eWaCS (e) {W ( , ) | s S}
where S= {s0, s1, s2,⋯, sJ} and J is the total number of scales without
s0.
Our recent work have shown the utility of the WaCS for char-
acterizing brain connectivity graphs by demonstrating its sensitivity in
detecting subtle group differences in bipolar disease (Kim et al., 2013)
and in family history of AD from preclinical AD data (Kim et al.,
2015a). The strength of the approach is that by comparing local context
of signals at each location, essentially higher order interaction terms, it
is possible to achieve much greater reliability and accuracy versus a
simple comparison of values at one resolution (which explains the
broad use of this idea in feature matching (Lowe, 1999, 2004; Morel
and Yu, 2009; Shen and Ip, 1999; Won et al., 2013)).
For the derivation of the WaCS, we used the Multi-resolution Brain
Connectivity Analysis (MBCA) toolbox (Kim et al., 2015a) together with
the Spectral graph wavelet toolbox (SGWT) (Hammond et al., 2011).
We obtained J= 5 scales of WaCS at each connection, then selected
s= 2, 3, 4 scales which contained the most information based on ob-
servation of the eigenspectrum of L(G). The distribution of eigenvalues
of graph Laplacian of L(G) demonstrated very small number of eigen-
values in scales corresponding to s= {0,1},and we removed s= 5 (i.e.,
high frequency components) considering it as a noise component. The
mother wavelet that was used in this study was a spline wavelet, which
is the default wavelet provided by SGWT toolbox.
2.6. Statistical analysis
Since WaCS is a multi-scale descriptor which aggregates informa-
tion from other fiber bundles neighboring to the fiber bundle of interest,
we performed an analysis based on a multivariate general linear model
(MGLM) at each connection to determine whether longitudinal con-
nectivity changes in white matter connectivity are influenced by AD
pathology or neural injury as indexed by each CSF biomarker. Under
Gaussian assumption, our model included the covariates of age, sex,
time interval between the longitudinal imaging visits (∆Time,
2.73 years in average), time interval between CSF collection (i.e.,
lumbar puncture) and baseline MRI (CSFtoMRI, 0.35 years in average),
the cohort (WRAP or Wisconsin ADRC) from which the participant was
recruited (Cohort) and the interaction term CSF× ∆Time. Because it
was generally the case that WRAP participants were scanned on one GE
3 T scanner, and ADRC participants on an identical but separate GE 3 T
scanner, we did not add an additional covariate for scanner (this was
largely accounted for by the “cohort” covariate). The primary outcome
was longitudinal changes in WaCS at each scale (i.e., ∆WaCS) which is
multivariate, and the primary predictor of interest was the interaction
CSF× ∆Time, where the variable CSF was an individual CSF biomarker
as expressed by:
= × + + + + ++WaCS CSF Time Age Sex Time CSF CSFtoMRICohort
which reflects a hypothesis that ∆WaCS is independent from the in-
teraction CSF× ∆Time. We chose to examine the interaction
CSF× ∆Time rather than a main effect of each CSF biomarker because
we expected there to be greater detectable changes in WaCS over longer
intervals between DTI scans. This interaction term indicates that CSF
biomarker level in addition to interval is important for predicting
changes in connectivity over time. This hypothesis test was applied to
WaCS of all existing connections using MGLM, and Wilks's λ was used
to compute p-values. After running MGLM for WaCS of all connections,
Bonferroni correction at α=0.05 was used to correct for multiple
comparisons. Effects surviving the correction for multiple comparisons
(i.e., showing lower p-values than the correction threshold) provide a
strong statistical evidence that the CSF biomarker together with the
MRI interval are associated with the longitudinal strength changes
observed in the WaCS representation of that connection. Since the
connectivity matrix for each brain used in our experiment was sparse
(i.e., only a few ROIs are structurally connected to each other) and
symmetric, the total number of tests performed over the whole brain
connectivity for a single CSF measure was 2964.
We tested the described model for each CSF biomarker of interest
and ΔWaCSFA derived from FA and ΔWaCSMD derived from MD.
Additionally, in order to investigate whether WaCS is more sensitive
than conventional analysis of simple DTI metrics, we performed the
same models as described above but substituted ΔFA or ΔMD in place of
∆WaCS. We again inferred significance of the model by examining the
CSF× ∆Time predictor using the Bonferroni correction.
In the next step, we extracted FA and MD from tracts that were
identified as significant in the WaCS model for further interrogation.
While WaCS provides a sensitive approach to identify statistical asso-
ciations, the underlying directional relationship between predictors and
outcomes is not observable in the WaCS representation due to its multi-
scale representation. Therefore, inferences about the directional asso-
ciation between the CSF biomarkers and the underlying white matter
microstructure were determined by Pearson correlations between the
CSF biomarker levels and the extracted simple MD and FA values from
the connectivities identified in the WaCS analyses. The Pearson corre-
lations are reported to facilitate interpretation of our primary findings
using WaCS, and corresponding scatter plots are demonstrated in the
W.H. Kim et al. NeuroImage: Clinical xxx (xxxx) xxxx
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Appendix.
3. Results
No significant brain connectivity edges were found between long-
itudinal simple MD/FA (i.e., raw measurements) and CSF measures of
Aβ42, t-tau and NFL even with our multi-resolution framework using
WaCS. However, we detected WaCS representations derived from sev-
eral brain connections that were statistically significant and meaningful
with p-tau and neurogranin together with longitudinal WaCS from MD
and FA, which are demonstrated in the following subsections.
3.1. Mean diffusivity and CSF biomarkers
We identified statistically significant associations between the
interaction between some CSF biomarkers (i.e., p-tau and neuro-
granin) and time (i.e., CSF× ∆Time) and ΔWaCSMD; the associated
p-values are reported in Tables 2 and 3. The left and middle panels in
Fig. 1 displays the p-values from ΔWaCSMD (blue) together with p-
values from simple MD analysis (green) and the Bonferroni threshold
(dashed red) in −log10 scale, where the connections above the
threshold are statistically significant. Significant associations were
identified with p-tau and neurogranin, but none with other CSF
biomarkers (i.e., Aβ42, t-tau, and NFL). In contrast to the WaCS
analyses, we detected only one connection for the p-tau analysis
when we used the simple MD values as a response variable. Of note,
this connection was also identified in ΔWaCSMD analyses.
3.1.1. Results from ΔWaCSMD and P-tau analysis
We identified 10 connections using ptau× ∆Time as in Fig. 1
(left), which are listed in Table 2 and visualized in Fig. 2. The top
row in Fig. 2 shows the fiber tracts reflecting the 10 connections
derived from tractography and the bottom row shows straight con-
nections between the centers of the ROIs where the thickness of the
connections represents the corresponding p-values (thicker connec-
tions denote lower p-values, i.e. a more robust association). These
connections span over 11 different ROIs (three on the left and eight
on the right hemisphere) including left and right amygdala, left and
right caudate, left transverse frontopolar gyrus/sulcus, right hippo-
campus, right frontomarginal gyrus/sulcus, right posterior ventral
cingulate gyrus, right middle frontal gyrus, right intraparietal sulcus
and right precentral superior regions. The significant connections
tended to show moderate positive (Pearson's) correlations between
the simple MD changes and the interaction (i.e., ptau× ∆Time),
ranging from 0.071 to 0.4041, indicating that increase in p-tau levels
is associated with increase in MD over time, where higher MD in-
dicates more diffusion possibly due to neurodegeneration.
Among the gray matter regions that were associated with altered
connections, right frontomarginal gyrus/sulcus had the greatest
number of associated connections with six, followed by right hip-
pocampus with three connections. Right amygdala and left caudate
were each associated with two altered connections. Among the
identified connections, three interconnected the two hemispheres: 1)
the connection between right frontomarginal gyrus/sulcus and left
transverse frontopolar gyrus/sulcus, 2) the left caudate and right
amygdala, 3) the left amygdala and the right hippocampus and 4) the
left caudate and right hippocampus. Note that while this analysis
shows the associations between structural connectivity and p-tau,
since WaCS is a multi-resolution representation, the association be-
tween p-tau may not necessarily be driven by the specific fiber
Table 2
Connections identified using ptau×∆Time as a predictor for longitudinal changes inWaCSMD (multiple comparisons corrected using Bonferroni at 0.05) sorted by
corresponding p-values (column 1–3), and the correlation between simple MD changes and ptau×∆Time on the identified connections (column 4). Two ROIs (i.e.,
ROI 1 and ROI 2) represent one connection and the ROI indices corresponds to their labels in the IIT template.
ROI 1 (IIT index) ROI 2 (IIT index) p-Value (1e-4) (WaCSMD) Correlation (simple MD)
ctx_rh_G_and_S_frontomargin (12101) ctx_rh_S_intrapariet_and_P_tran (12157) 0.0014 0.3157
ctx_rh_G_and_S_frontomargin (12101) ctx_lh_G_and_S_transv_frontopol (11105) 0.0046 0.0711
Right-Hippocampus (53) ctx_rh_G_and_S_frontomargin (12101) 0.0147 0.3671
ctx_rh_G_and_S_frontomargin (12101) ctx_rh_G_front_middle (12115) 0.0225 0.2554
Right-Amygdala (54) ctx_rh_G_cingulum-Post-ventral (12110) 0.0274 0.3026
Left-Caudate (11) Right-Amygdala (54) 0.0776 0.3071
ctx_rh_G_and_S_frontomargin (12101) ctx_rh_S_precentral-sup-part (12170) 0.0859 0.2507
Right-Caudate (50) ctx_rh_G_and_S_frontomargin (12101) 0.1022 0.4041
Right-Hippocampus (53) Left-Amygdala (18) 0.1270 0.3483
Left-Caudate (11) Right-Hippocampus (53) 0.1611 0.2017
ctx: cortex, lh: left hemisphere, rh: right hemisphere, S: sulcus, G: gyrus, sup: superior, inf: inferior, post: posterior, frontomargin: frontomarginal, pariet: parietal,
tran/transv: transverse, frontopol: frontopolar.
Table 3
Connections identified using neurogranin×∆Time as a predictor for longitudinal changes in WaCSMD (multiple comparisons corrected using Bonferroni at 0.05)
sorted by corresponding p-values (column 1–3), and the correlation between simple MD changes and neurogranin×∆Time on the identified connections (column
4). Two ROIs (i.e., ROI 1 and ROI 2) represent one connection and the ROI indices corresponds to their labels in the IIT template.
ROI 1 (IIT index) ROI 2 (IIT index) p-Value (1e-4) (WaCSMD) Correlation (simple MD)
ctx_rh_G_and_S_frontomargin (12101) ctx_rh_S_intrapariet_and_P_tran (12157) 0.0053 0.3180
ctx_rh_G_and_S_frontomargin (12101) ctx_lh_G_and_S_transv_frontopol (11105) 0.0068 0.0884
ctx_rh_G_and_S_frontomargin (12101) ctx_rh_G_front_middle (12115) 0.0099 0.2637
ctx_rh_G_and_S_frontomargin (12101) ctx_rh_G_insular_short (12118) 0.0145 0.0986
ctx_rh_G_and_S_frontomargin (12101) ctx_rh_G_pariet_inf-Angular (12125) 0.0236 0.2277
Right-Hippocampus (53) ctx_rh_G_and_S_frontomargin (12101) 0.0481 0.3131
Right-Caudate (50) ctx_rh_G_and_S_frontomargin (12101) 0.0519 0.3535
Right-Hippocampus (53) ctx_lh_G_parietal_sup (11127) 0.1462 0.2751
ctx_rh_G_and_S_frontomargin (12101) ctx_rh_S_precentral-sup-part (12170) 0.1564 0.2460
ctx_rh_G_and_S_frontomargin (12101) ctx_rh_G_and_S_paracentral (12103) 0.1597 0.1183
ctx: cortex, lh: left hemisphere, rh: right hemisphere, S: sulcus, G: gyrus, sup: superior, inf: inferior, post: posterior, frontomargin: frontomarginal, pariet: parietal,
tran/transv: transverse, frontopol: frontopolar.
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Fig. 1. Sorted resultant p-values from analyses usingWaCSMD(blue) and simple MD (green) with CSF biomarkers (i.e., p-tau and neurogranin). Bonferroni threshold
(dashed red) at α= 0.05 in −log10 scale are shown together. The connections surviving (above) the multiple comparisons threshold are the connections significantly
associated with CSF biomarkers. Left: WaCSMD and p-tau, Right: WaCSMD and neurogranin.
Fig. 2. Visualization of identified brain connections whose longitudinal MD changes are dependent on p-tau (i.e. ptau× ∆Time). Top: visualization of tractography
generated tracts from the identified connectivity where the tracts in the same color belong to the same connectivity, Bottom: lines representing the identified
connections with thickness corresponding to the p-values, where thicker line corresponds to lower p-value and ROI indices. Left: top view, Middle: left view, Right:
right view.
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bundle, entirely by itself.
3.1.2. Results from ΔWaCSMD and neurogranin analysis
Using the interaction between neurogranin and MRI time interval
(i.e., neurogranin× ∆Time) as the main predictor for the longitudinal
changes in ΔWaCSMD, we also found 10 connections (listed in Table 3)
with low p-values surviving Bonferroni correction at α=0.05. The p-
values and correction threshold in −log10 scale are shown in Fig. 1
(right). The 10 identified connections, as visualized in Fig. 3, were
present across 11 different ROIs (two on the left and nine on the right
hemisphere). Interestingly, most of the significant connections (nine
out of 10) were associated with right frontomarginal gyrus/sulcus and
two connections were found with right hippocampus. The hippocampus
is well documented as a key region affected in all stages of Alzheimer's
disease. Studies have also consistently found atrophy within the frontal
lobes in Alzheimer's disease, including ROIs overlapping with the
frontomarginal gyrus (Burgmans et al., 2009; Du et al., 2007; Singh
et al., 2006). The correlations between the longitudinal change in
simple MD and the interaction neurogranin× ∆Time also showed small
to moderate positive correlations ranging from 0.0884 to 0.3535, in-
dicating that as neurogranin increases, there is a corresponding increase
in MD in these tracts. Of course, similar to the associations with p-tau,
since WaCS is a multi-resolution representation, we cannot conclude
that the associations are entirely driven by the specific fiber bundle,
entirely by itself.
Results of the analysis of p-tau and analysis of neurogranin re-
vealed 6 shared connections: 1) right frontomarginal gyrus/sulcus
and right intraparietal sulcus, 2) right frontomarginal gyrus/sulcus
and right transverse frontopolar gyrus/sulcus, 3) right frontomar-
ginal gyrus/sulcus and right frontal middle, 4) right frontomarginal
gyrus/sulcus and right hippocampus, 5) right frontomarginal gyrus/
sulcus and right precentral sulcus and 6) right frontomarginal gyrus/
sulcus and right caudate. Of note, all the common connections (in
terms of their WaCS representations) were associated with right
frontomarginal gyrus and sulcus.
3.2. Fractional anisotropy and CSF biomarkers
Using ΔWaCSFA and neurogranin× ∆Time, three out of 2964
connections were statistically associated with neurogranin as listed
in Table 4; we did not find any significant connections using other
CSF biomarkers. In this experiment, fewer connections survived the
multiple comparisons correction using Bonferroni at 0.05. The p-
values for the identified connections are shown in Fig. 4 with Bon-
ferroni correction thresholds, and the identified connections are vi-
sualized in Fig. 5. As shown in Fig. 4, no significant associations were
Fig. 3. Visualization of identified brain connections whose longitudinal MD changes are dependent on neurogranin (i.e., neurogranin× ∆Time). Top: visualization
of tractography generated tracts from the identified connectivity where the tracts in the same color belong to the same connectivity, Bottom: lines representing the
identified connections with thickness corresponding to the p-values. Thicker line corresponds to lower p-value. Left: top view, Middle: left view, Right: right view.
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identified using the simple FA values. Five different ROIs were in-
volved in the identified connections: left paracentral gyrus/sulcus,
left postcentral gyrus, left cingulate Marginalis sulcus, left sub-
parietal sulcus, left central sulcus. While most of the identified
connections in the previous ΔWaCSMD analyses were found on the
right hemisphere, the ΔWaCSFA analysis yielded connections only in
the left hemisphere. The only ROI in common between WaCSMD and
WaCSFA analyses was left paracentral gyrus/sulcus.
Again, we computed the correlation between the changes in simple
FA and the interaction neurogranin× ∆Time. The correlations were
mostly moderate ranging between −0.4022 and −0.3448. As expected
given the inverse relationship between MD and FA, the correlations
were negative which means that the changes in FA decrease (i.e., di-
rectional coherence of the white matter fiber tract decreases) with in-
creases in neurogranin× ∆Time.
4. Discussion
Several neuroimaging studies confirm that white matter degenera-
tion is a feature of AD and other dementias, and that degeneration
occurs across disease development (Acosta-Cabronero et al., 2010; Liu
et al., 2017; Steketee et al., 2016; Zhuang et al., 2010). However, few
longitudinal studies have been carried out, especially studies in cogni-
tively asymptomatic individuals. In the current study, we examined
longitudinal change and employed a novel multi-resolution graph
analysis method which offers very high sensitivity for identifying as-
sociations between connectivity graphs (in terms of hybrid local-global
representations) and neuropathology. We found that elevated CSF p-tau
and neurogranin predicted changes in white matter connection strength
after correction for multiple comparisons. Using a conventional ap-
proach for analysing FA and MD with GLM did not yield sufficient
sensitivity to detect subtle changes at a statistically significant
threshold across the entire brain.
The development of AD from the preclinical to the dementia stage
involves progressive accumulation of cortical pathology. In addition
to development of amyloid plaques and neurofibrillary tangles, ad-
ditional disease features include neural injury, resulting in loss of
synaptic connections and axonal loss which results in a disconnection
of more distal brain regions (Perez-Nievas et al., 2013). Of the AD-
specific and neural injury biomarkers, only p-tau and neurogranin
were significant predictors of change in connectivity strength. It is
intriguing that these two markers were associated with loss of con-
nectivity, given several reports that tau pathology may spread via
synaptically connected circuits (De Calignon et al., 2012; Liu et al.,
2012). Neurogranin, a postsynaptic protein enriched in the brain and
primarily localized in the cortex, hippocampus, and amygdala, is
thought to reflect synaptic loss and several studies indicate that CSF
neurogranin levels are elevated in patients with AD and MCI com-
pared to controls (Hellwig et al., 2015; Kvartsberg et al., 2015;
Thorsell et al., 2010). Elevated neurogranin also appears specific to
AD compared to other neurodegenerative diseases (Portelius et al.,
2018; Wellington et al., 2016). There was considerable overlap be-
tween the p-tau and neurogranin findings, particularly for connec-
tions within the frontal lobe, and connections between the frontal
lobe and the hippocampus as well as parietal ROIs, possibly re-
flecting propagation of tau pathology via axonally connected re-
gions. Hippocampal involvement in AD is present in Braak stages II
and III of the disease process, and in our study, hippocampus showed
2 abnormal connections in each of the p-tau and neurogranin ana-
lyses. Tangle development in high order association cortices — in-
cluding the frontal and parietal cortices detected in this study — do
not occur until Braak stage IV; however, prior to dense tangle ac-
cumulation, tau abnormalities appear in axons, and at least one
mouse study has shown that abnormalities can be detected using
diffusion weighted imaging, even at the early stage of disease de-
velopment prior to severe tauopathy (Sahara et al., 2014). Further
interrogation of temporal ordering of connectivity loss and regional
neurofibrillary tangle development will require regional mapping of
tau pathology in conjunction with diffusion weighted imaging
(Hwang et al., 2018b). A caveat of this interpretation in our study is
that while hyperphosphorylation of tau protein is known to begin
within the axon, we did not observe a relationship between NFL and
connectivity strength. CSF NFL levels (a marker of axonal injury) are
elevated in AD and predict faster disease progression (Zetterberg
et al., 2016). NFL is consistently elevated among individuals with
more advanced pathology, so it may be the case that an association
between NFL and connectivity change is not observed until later
disease stages.
While WaCS provides a sensitive tool for detecting significant
Table 4
Connections identified using neurogranin×∆Time as a predictor for longitudinal changes in WaCSFA (multiple comparisons corrected using Bonferroni at 0.05)
sorted by corresponding p-values (column 1–3), and the correlation between simple FA changes and neurogranin×∆Time on those identified connections (column
4). Two ROIs (i.e., ROI 1 and ROI 2) represent one connection and the ROI indices corresponds to their labels in the IIT template.
ROI 1 (IIT index) ROI 2 (IIT index) p-Value (1e-4) (WaCSFA) Correlation (simple FA)
ctx_lh_G_and_S_paracentral (11103) ctx_lh_G_postcentral (11128) 0.0155 −0.3448
ctx_lh_S_cingulum-Marginalis (11147) ctx_lh_S_subparietal (11172) 0.0815 −0.3736
ctx_lh_G_and_S_paracentral (11103) ctx_lh_S_central (11146) 0.0924 −0.4022
ctx: cortex, lh: left hemisphere, rh: right hemisphere, S: sulcus, G: gyrus, sup: superior, inf: inferior, post: posterior, frontomargin: frontomarginal, pariet: parietal,
tran/transv: transverse, frontopol: frontopolar.
Fig. 4. Sorted resultant p-values from analysis usingWaCSFA (blue) and simple
FA (green) with neurogranin. Bonferroni threshold at α= 0.05 in −log10 scale
is shown in dotted red. The connections surviving (above) the multiple com-
parisons threshold are the connections significantly associated with neuro-
granin.
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differences or associations, it does not provide the direction of the
association. To accomplish this, we extracted FA and MD values from
regions that were detected using WaCS and computed correlations
between the FA/MD values and the interaction between CSF bio-
markers and time intervals. The correlations between p-tau and
neurogranin and WaCSMD connections were all moderately positive,
indicating that more tangle pathology and synaptic degeneration are
associated with weakened connectivity strength over time. CSF
neurogranin, but not p-tau, was also a significant predictor of
WaCSFA. While fewer connections overall reached statistical sig-
nificance, as expected, these correlations were all negative with
higher neurogranin being associated with weaker connection
strength. Separately, since WaCS is a multi-resolution representation,
localizing a significant association to a fiber bundle by itself is pro-
blematic since the signal at other adjacent fiber bundles (in the graph
sense) may nominally contribute to the derived WaCS representa-
tion.
At an uncorrected threshold, CSF biomarkers predicted change in
simple FA and MD in a similar pattern to that found using WaCS. This
consistent pattern demonstrates that FA and MD still remain useful
measures for assessing microstructure, particularly in analyses that
involve an a priori driven hypothesis for which there are few mul-
tiple comparisons. WaCS, however, provides a sensitive method for
detecting subtle effects across the entire brain, which requires
correction for multiple comparisons given the thousands of hypoth-
esis tests. WaCS captures subtle variations that are represented in
multiple bandwidths in the frequency space, which may not manifest
in the original space taking into account signal at multiple resolu-
tions. This approach can be particularly useful for detecting changes
in the preclinical stages of disease. Indeed, this framework could be
adopted for the analysis of other preclinical diseases, not just AD. No
relationships were observed with markers of amyloid. Thus, it may
be the case that our findings represent early AD-related connectivity
changes that are independent of amyloid. Alternatively, p-tau levels
and associated white matter degeneration observed in the population
studied here may reflect a process independent of AD, such as sus-
pected non-Alzheimer's pathology (SNAP) (Knopman et al., 2013) or
primary age-related tauopathy (PART) (Crary et al., 2014). Elevated
neurogranin could also reflect age-related rather than AD-related loss
of synapses and plasticity. Because our study population is a pre-
clinical cohort and the course of AD occurs simultaneously with age-
related or other disease-related brain changes, it is likely that both
AD and non-AD pathological changes may underlie some of the ob-
served white matter alterations as demonstrated in this study.
We find that the multi-resolution analysis using WaCS outper-
forms traditional approaches with the raw measures for various
reasons. First, the multi-resolution view of a signal on each data
point (e.g., pixel in an image or node/edge on a graph) yields its
Fig. 5. Visualization of the identified brain connections whose longitudinal FA changes are dependent on neurogranin (i.e., neurogranin× ∆Time). Top: visua-
lization of tractography generated tracts from the identified connectivity where the tracts in the same color belong to the same connectivity, Bottom: lines re-
presenting the identified connections with thickness corresponding to the p-values. Thicker line corresponds to lower p-value. Left: top view, Middle: left view, Right:
right view.
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relationship with the signal on its neighboring data points (i.e., local
context) by applying a filter at different scales. Such a technique is
well known in computer vision and image processing to yield robust
comparisons (Morel and Yu, 2009). Also, the idea of the multi-re-
solution shares similarities with feature extraction using convolution
neural network (CNN), which derives features by applying multiple
filters with different parameters to achieve novel representation of
an image. In the end, our multi-resolution approach makes the true
signal stronger in the locations where the p-values with the raw
measure are low but not enough to survive multiple comparisons
corrections due to small sample size or small effect size, without
increasing false positives, by aggregating information based on the
topology of the graph. Although not reported in this manuscript for
simplicity, we empirically tested the uni-resolution version of WaCS
based on using only a single scale which turned out to be ineffective
in the current study as well as other previous studies (Kim et al.,
2015a; 2014). This scheme returned improved results but quite si-
milar to only using FA or MD values directly.
Note that since WaCS is derived using graph wavelets, it is lever-
aging various properties of well-studied concepts from physics such as
diffusion or heat equation. Diffusion has been shown to be closely re-
lated to wavelets in earlier papers (Coifman and Maggioni, 2006). Se-
parate from this body of work, diffusion or heat equation based op-
erators have been used to better understand the physical process of
pathology propagation (Raj et al., 2012; 2015) by essentially treating
the structural connectivity network as physical “pathways” to explain
the spatial distribution of pathology at a subsequent time point. This
suggests that ideas related to our multi-resolution WaCS may provide
efficient ways to investigate pathology propagation, if an appropriate
imaging modality (such as amyloid PET) is available for the partici-
pants. A preliminary attempt to investigate this hypothesis is presented
in (Hwang et al., 2018b).
4.1. Limitations
WaCS is a sensitive and effective way for characterizing connection
strength of white matter tracts in a multi-resolution (hybrid global-
local) manner; however, it is not without its limitations. Multi-resolu-
tion strategy deriving WaCS involves a quadratic increase of compu-
tation depending on the number of connections (i.e., O(|E|2)) during
the transformation between G and L(G). When the given brain con-
nectivity (i.e., graph) is dense, this can pose a problem, however the
number of ROIs studied here was relatively small (< 200) and their
connections were sparse. Specifying parameters (i.e., number of scales
J, choice of scales and choice of a type of wavelet) also requires a
heuristic input from the user, which in turn may affect the statistical
power of the analysis. It is also important to note that WaCS is a re-
presentation of the connectivity that embeds the strength of the con-
nections in a high dimensional space where the direction of the asso-
ciations become ambiguous. Therefore, additional analysis is required
to make further inferences about the underlying microstructure.
Finally, association studies using WaCS provide useful information re-
garding structural connectivity captured in a global-local sense in the
context of one or more predictors. However, the association may not
necessarily be limited to a specific fiber bundle due to the inherent
multi-resolution representation. Aside from the technical issues with
WaCS, an additional limitation of this study was the use of DTI model
for diffusion MRI, which may not capture the crossing white matter
fibers in the white matter connectivity construction that may have been
affected by some of the CSF measures. Also, the lateralization of results
where associations between CSF and MD were primarily observed in the
right cortex and with FA in the left cortex is an interesting finding to
note but remains unclear and need to be further investigated as an
important future study. Finally, while this study is an improvement
over cross-sectional analyses, our study included only two time-points
over a relatively short interval (~3 years on average). Considering that
pre-clinical pathology may begin decades prior to clinical impairment,
longer follow-up is needed.
5. Conclusion
While white matter alteration is an increasingly recognized feature
of neurodegeneration, the relationship between cortical pathology and
degeneration of underlying white matter tracts remains poorly defined.
The present study demonstrated that elevated levels of biomarkers of
both neurofibrillary tangles and synaptic dysfunction are associated
with altered connectivity over several years. Using techniques that
provide superior sensitivity to connectivity changes such as WaCS, are
expected to facilitate the understanding of the earliest stages of disease.
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Appendix A
In this appendix, we demonstrate figures of scatter plots using the longitudinal connectivity strength changes (i.e., FA and MD measures) and the
main predictor (i.e. interaction between a CSF measure and longitudinal imaging visits) on the brain connectivities that we identified in our study.
A.1. MD and p-tau analysis
Our analysis on WaCS from MD and p-tau identified 10 connectivities that showed statistically significant associations. In the following, we
demonstrate the scatter plots using simple MD measure and interaction term (i.e., ptau× ∆Time) from each of the identified connections. In each of
the figure, the title shows the ROIs associated with each connection, the x-axis is the interaction and the y-axis reflects the longitudinal MD changes.
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A.2. MD and neurogranin analysis
Our analysis on WaCS from MD and neurogranin identified 10 connectivities that showed statistically significant associations. In the following,
we demonstrate the scatter plots using simple MD measure and interaction term (i.e., neurogranin×∆Time) from each of the identified connections.
In each of the figure, the title shows the ROIs associated with each connection, the x-axis is the interaction and the y-axis reflects the longitudinal MD
changes.
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A.3. FA and neurogranin analysis
Our analysis on WaCS from FA and neurogranin identified 3 connectivities that showed statistically significant associations after Bonferroni
correction. In the following, we demonstrate the scatter plots using simple FA measure and interaction term (i.e., neurogranin×∆Time) from each of
the identified connections. In each of the figure, the title shows the ROIs associated with each connection, the x-axis is the interaction and the y-axis
reflects the longitudinal MD changes.
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